# SELENIOUS ACID
> **ANDA220051** · Abbreviated New Drug Application (Generic) · Sponsor: BPI LABS LLC · Approved 2026-01-07
## Drug
- **FDA Application Number:** ANDA220051
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SELENIOUS ACID
- **Generic name:** Selenious Acid
- **Active ingredients:** SELENIOUS ACID
- **Dosage form:** INJECTION
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** BPI LABS LLC
- **First approval:** 2026-01-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220051)
---
*AI Analytics · CC0 1.0*